Thom Mangan

Thom Mangan

A 20-year veteran in the field of employee benefits, Mr. Mangan has been named one of the top 10 most influential individuals in the health care industry by Employee Benefits News and is widely recognized as one of the industry's most progressive thought leaders. His extensive background in employee benefits spans sales, services and operations. Prior to joining UBA, Mangan was a Board Member of the Council of Insurance Agents and Brokers and has served on the National Broker Advisory Councils of Aetna, Cigna and United Healthcare.
  • SHOP exchanges — hurry up and wait!

    A breakdown of the potential impact seen already from the SHOP exchange delay.
  • How to best inform employees about ‘Obamacare’

    Even though education has long been considered key for most employee benefits programs, it’s still not easy to engage employees.
  • Battling PBM costs

    As CEO of United Benefit Advisors, I hear continually about the issues facing our 36,000 employer clients. Managing prescription drug costs continues to be paramount. The UBA 2012 Health Plan Survey shows that 64.2% of prescription drug plans utilize three co-pay tiers (generic, formulary brand, and non-formulary brand); 2.9% have a one-tier plan, 8.2% retain a two-tier plan; and 24.7% add a fourth tier (specialty). Consultants should watch these plan structures carefully as many brand-name drugs go off their patents and pricing is determined for the influx of generic drugs. On the other end of the spectrum, we're watching increases in specialty drugs, which are driving up costs significantly.
  • Localized data in the wake of PPACA

    The recent ruling on health reform has created an even greater need for accurate benchmarking data. Proving the age old adage that if you can't measure it, then you can't manage it. Advisers armed with information that drills down through national, regional, state, industry and company size will be better prepared to assist larger employers with employee acquisition and retention, and smaller employers make intelligent decisions on whether or not to "pay or play."